Hydrocortisone Sodium Phosphate
A water-soluble sodium phosphate salt form of hydrocortisone used in injectable formulations for the acute treatment of severe allergic reactions, asthma attacks, adrenal crisis, and severe inflammation. Its high solubility allows rapid intravenous or intramuscular administration in emergency situations. This formulation provides fast onset of corticosteroid effect when oral treatment is not feasible.
आणविक भार
486.4000 g/mol
TPSA
147.00 Ų
चिकित्सीय क्षेत्र
क्रिया का तंत्र
Binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene transcription. This suppresses multiple inflammatory genes encoding cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory proteins.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene transcription. This suppresses multiple inflammatory genes encoding cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory proteins.
2D संरचना
Cite this structure
Embed this structure
SMILES
C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]
InChI
InChI=1S/C21H31O8P.2Na/c1-19-7-5-13(22)9-12(19)3-4-14-15-6-8-21(25,17(24)11-29-30(26,27)28)20(15,2)10-16(23)18(14)19;;/h9,14-16,18,23,25H,3-8,10-11H2,1-2H3,(H2,26,27,28);;/q;2*+1/p-2/t14-,15-,16-,18+,19-,20-,21-;;/m0../s1
Molecular Formula
C21H29Na2O8P
HBD / HBA
2 / 8
घूर्णनीय बंधन
3
भारी परमाणु
32
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
अक्सर पूछे जाने वाले प्रश्न
A water-soluble sodium phosphate salt form of hydrocortisone used in injectable formulations for the acute treatment of severe allergic reactions, asthma attacks, adrenal crisis, and severe inflammation. Its high solubility allows rapid intravenous or intramuscular administration in emergency situations. This formulation provides fast onset of corticosteroid effect when oral treatment is not feasible.
Binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene transcription. This suppresses multiple inflammatory genes encoding cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory proteins.
Yes, Hydrocortisone Sodium Phosphate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200968. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 441406. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="hydrocortisone-sodium-phosphate"></div>
Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/hydrocortisone-sodium-phosphate/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>
Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/hydrocortisone-sodium-phosphate/
Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/hydrocortisone-sodium-phosphate/)
Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="hydrocortisone-sodium-phosphate"></drugfyi-drug>